ANTIBODY DRUG CONJUGATES AND BEYOND:

The discovery and development of breakthrough targeted therapies for cancer treatment

ANTIBODY DRUG CONJUGATES AND BEYOND:

We are focused on discovering and developing antibody-drug conjugates (ADCs) against novel targets as breakthrough therapeutics for the treatment of advanced stage solid tumors.

OUR MISSION

We are focused on discovering and developing antibody-drug conjugates (ADCs) against novel targets as breakthrough therapeutics for the treatment of advanced stage solid tumors.

Learn More

Technology

Pipeline

WNTRIX INC

Wntrix Inc. is a preclinical-stage biotechnology company aiming to discover and develop novel therapeutics using the antibody drug conjugate (ADC) approach for solid tumors. Wntrix was founded in 2014 at Houston, Texas.